NCT02215720 2026-03-20
TORERO
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1 Completed
Clinical Trials
5 trialsNCT00996567 2017-02-09
MesoMab
University Hospital, Ghent
Phase 2 Completed
NCT00388427 2015-05-28
Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid Malignancies
University of Pittsburgh
Phase 1 Completed
NCT01702129 2014-09-09
Anti-EGFR Immunoliposomes in Solid Tumors
University Hospital, Basel, Switzerland
Phase 1 Completed
NCT00376727 2010-03-29
Cetuximab in Treating Patients With Advanced Solid Tumors
University of California, Davis
Phase 1 Completed